SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Azul S.A. (AZUL) , forward earnings yield 384.62%.
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+900%).
- Forward P/E 0.3
- Analyst consensus target $5.00 (+900% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 38/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AZUL
Valuation Multiples
P/E (TTM)0.0
Forward P/E0.3
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-78.96
Forward EPS (Est.)$1.94
Book Value / Share$0.00
Revenue / Share$168.49
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield384.62%
Dividend Yield0.00%
Analyst Target$5.00 (+900%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-9.78 |
$6.26B |
$-1.07B |
-17.2% |
| 2016 |
$-1.14 |
$6.67B |
$-126.31M |
-1.9% |
| 2017 |
$3.96 |
$7.79B |
$529M |
6.8% |
| 2018 |
$-5.64 |
$9.2B |
$703.6M |
7.6% |
| 2019 |
$-21.15 |
$11.44B |
$823.7M |
7.2% |
| 2020 |
$-88.83 |
$5.74B |
$-10.83B |
-188.6% |
| 2021 |
$-41.37 |
$9.98B |
$-4.21B |
-42.2% |
| 2022 |
$-11.91 |
$15.95B |
$-722.37M |
-4.5% |
| 2023 |
$-20.55 |
$18.55B |
$-2.38B |
-12.8% |
| 2024 |
$-78.96 |
$19.53B |
$-9.15B |
-46.9% |
